152 related articles for article (PubMed ID: 30216198)
1. Noninvasive Administration of Inhaled Epoprostenol and Inhaled Milrinone in Extubated, Spontaneously Breathing Patients With Right Ventricular Failure and Portal Hypertension: A Report of 2 Cases.
Couture EJ; Tremblay JA; Elmi-Sarabi M; Lamarche Y; Denault AY
A A Pract; 2019 Mar; 12(6):208-211. PubMed ID: 30216198
[TBL] [Abstract][Full Text] [Related]
2. The additive pulmonary vasodilatory effects of inhaled prostacyclin and inhaled milrinone in postcardiac surgical patients with pulmonary hypertension.
Haraldsson s A; Kieler-Jensen N; Ricksten SE
Anesth Analg; 2001 Dec; 93(6):1439-45, table of contents. PubMed ID: 11726420
[TBL] [Abstract][Full Text] [Related]
3. Point-of-Care Ultrasonography to Assess Portal Vein Pulsatility and the Effect of Inhaled Milrinone and Epoprostenol in Severe Right Ventricular Failure: A Report of 2 Cases.
Tremblay JA; Beaubien-Souligny W; Elmi-Sarabi M; Desjardins G; Denault AY
A A Case Rep; 2017 Oct; 9(8):219-223. PubMed ID: 28604468
[TBL] [Abstract][Full Text] [Related]
4. Preliminary experience with combined inhaled milrinone and prostacyclin in cardiac surgical patients with pulmonary hypertension.
Laflamme M; Perrault LP; Carrier M; Elmi-Sarabi M; Fortier A; Denault AY
J Cardiothorac Vasc Anesth; 2015 Feb; 29(1):38-45. PubMed ID: 25440627
[TBL] [Abstract][Full Text] [Related]
5. Inhaled milrinone and epoprostenol in a patient with severe pulmonary hypertension, right ventricular failure, and reduced baseline brain saturation value from a left atrial myxoma.
St-Pierre P; Deschamps A; Cartier R; Basmadjian AJ; Denault AY
J Cardiothorac Vasc Anesth; 2014 Jun; 28(3):723-9. PubMed ID: 23623891
[No Abstract] [Full Text] [Related]
6. [The pulmonary vasodilatory effect of inhaled prostacyclin and milrinone in heart].
Ricksten S
Rev Esp Anestesiol Reanim; 2001 Dec; 48(10):460-1. PubMed ID: 11792300
[TBL] [Abstract][Full Text] [Related]
7. Pulmonary Vasodilator Response of Combined Inhaled Epoprostenol and Inhaled Milrinone in Cardiac Surgical Patients.
Elmi-Sarabi M; Jarry S; Couture EJ; Haddad F; Cogan J; Sweatt AJ; Rousseau-Saine N; Beaubien-Souligny W; Fortier A; Denault AY
Anesth Analg; 2023 Feb; 136(2):282-294. PubMed ID: 36121254
[TBL] [Abstract][Full Text] [Related]
8. Successful transition from intravenous to inhaled prostacyclin in a patient with pulmonary hypertension and right ventricular failure.
Reddy MT; Patel H; Ventura HO
Congest Heart Fail; 2008; 14(5):285-6. PubMed ID: 18983294
[No Abstract] [Full Text] [Related]
9. Inhaled Pulmonary Vasodilator Therapy for Management of Right Ventricular Dysfunction after Left Ventricular Assist Device Placement and Cardiac Transplantation.
Sabato LA; Salerno DM; Moretz JD; Jennings DL
Pharmacotherapy; 2017 Aug; 37(8):944-955. PubMed ID: 28543813
[TBL] [Abstract][Full Text] [Related]
10. Comparison of inhaled and intravenous milrinone in patients with pulmonary hypertension undergoing mitral valve surgery.
Wang H; Gong M; Zhou B; Dai A
Adv Ther; 2009 Apr; 26(4):462-8. PubMed ID: 19381522
[TBL] [Abstract][Full Text] [Related]
11. Refractory Cardiogenic Shock from Right Ventricular Infarction Successfully Managed with Inhaled Epoprostenol.
Held N; Little N; Krantz MJ; Stauffer BL
Am J Case Rep; 2017 Mar; 18():271-275. PubMed ID: 28298620
[TBL] [Abstract][Full Text] [Related]
12. Inhaled Epoprostenol and Milrinone Effect on Right Ventricular Pressure Waveform Monitoring.
Elmi-Sarabi M; Couture E; Jarry S; Saade E; Calderone A; Potes C; Denault A
Can J Cardiol; 2023 Apr; 39(4):474-482. PubMed ID: 36528279
[TBL] [Abstract][Full Text] [Related]
13. Intraoperative use of inhaled PGI(2) for acute pulmonary hypertension and right ventricular failure.
Schroeder RA; Wood GL; Plotkin JS; Kuo PC
Anesth Analg; 2000 Aug; 91(2):291-5. PubMed ID: 10910834
[TBL] [Abstract][Full Text] [Related]
14. Preliminary experience with inhaled milrinone in cardiac surgery.
Lamarche Y; Perrault LP; Maltais S; Tétreault K; Lambert J; Denault AY
Eur J Cardiothorac Surg; 2007 Jun; 31(6):1081-7. PubMed ID: 17400468
[TBL] [Abstract][Full Text] [Related]
15. A retrospective comparison of inhaled milrinone and iloprost in post-bypass pulmonary hypertension.
Theodoraki K; Thanopoulos A; Rellia P; Leontiadis E; Zarkalis D; Perreas K; Antoniou T
Heart Vessels; 2017 Dec; 32(12):1488-1497. PubMed ID: 28717881
[TBL] [Abstract][Full Text] [Related]
16. Inhaled Iloprost Versus Epoprostenol in Heart Transplant Recipients.
Enomoto TM; Treggiari MM; Yanez ND; Merkel MJ
Respir Care; 2019 Jul; 64(7):743-751. PubMed ID: 30967439
[TBL] [Abstract][Full Text] [Related]
17. Femoral Vein Pulsatility: What Does It Mean?
Calderone A; Hammoud A; Jarry S; Denault A; Couture EJ
J Cardiothorac Vasc Anesth; 2021 Aug; 35(8):2521-2527. PubMed ID: 33985881
[TBL] [Abstract][Full Text] [Related]
18. Use of aerosolized inhaled epoprostenol in the treatment of portopulmonary hypertension.
Schroeder RA; Rafii AA; Plotkin JS; Johnson LB; Rustgi VK; Kuo PC
Transplantation; 2000 Aug; 70(3):548-50. PubMed ID: 10949204
[TBL] [Abstract][Full Text] [Related]
19. Inhaled Milrinone After Left Ventricular Assist Device Implantation.
Haglund NA; Burdorf A; Jones T; Shostrom V; Um J; Ryan T; Shillcutt S; Fischer P; Cox ZL; Raichlin E; Anderson DR; Lowes BD; Dumitru I
J Card Fail; 2015 Oct; 21(10):792-7. PubMed ID: 25937146
[TBL] [Abstract][Full Text] [Related]
20. A multicentre randomized-controlled trial of inhaled milrinone in high-risk cardiac surgical patients.
Denault AY; Bussières JS; Arellano R; Finegan B; Gavra P; Haddad F; Nguyen AQN; Varin F; Fortier A; Levesque S; Shi Y; Elmi-Sarabi M; Tardif JC; Perrault LP; Lambert J
Can J Anaesth; 2016 Oct; 63(10):1140-1153. PubMed ID: 27470232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
